Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Marker, Biological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07741981
What this trial is testing

Treatment Resistance in Psychiatric Disorders: the Search for Biological Markers Predictive of Response to Treatment

Who this might be right for
SchizophreniaTreatment Resistant Depression (TRD)Bipolar Disorder (BD)+2 more
Centre Hospitalier St Anne 700
Testing effectiveness (Phase 2)Looking for participantsNCT06562920
What this trial is testing

Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer

Who this might be right for
Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer
Zhejiang Cancer Hospital 20
Not applicableStudy completedNCT00816088
What this trial is testing

Diagnostic and Management Strategies for Invasive Aspergillosis

Who this might be right for
Invasive AspergillosisNeutropenia
King's College Hospital NHS Trust 203
Testing effectiveness (Phase 2)Looking for participantsNCT06344260
What this trial is testing

Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis (STEMALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Casa Sollievo della Sofferenza IRCCS 30
Testing effectiveness (Phase 2)Study completedNCT00397696
What this trial is testing

Evaluation of 5-[123I]-A-85380 and SPECT Imaging in Individuals With Parkinsons Disease

Who this might be right for
Parkinson Disease
Institute for Neurodegenerative Disorders 9
Not applicableUnknownNCT02203227
What this trial is testing

Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia

Who this might be right for
Chronic SmokersHyperlipidemia
Olive Lifesciences Pvt Ltd 60
Not applicableStudy completedNCT04074642
What this trial is testing

OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.

Who this might be right for
Pituitary Adenoma
Centre Hospitalier Universitaire de Nice 21
Not applicableStudy completedNCT02697903
What this trial is testing

Pomegranate Improve Biological Recovery Kinetics in Elite Weightlifter

Who this might be right for
Healthy
The Higher Institute of Sport and Physical Education of Sfax 9
Not applicableLooking for participantsNCT05540561
What this trial is testing

Biological Diagnosis and Monitoring of Chronic Nitrous Oxide Abuse

Who this might be right for
Nitrous Oxide Abuse
University Hospital, Lille 356
Not applicableStudy completedNCT05164679
What this trial is testing

Training in a Local Community Aimed Upon Musculoskeletal Health Promotion for Postmenopausal Women

Who this might be right for
Age-Related Osteoporosis
University of Copenhagen 28
Not applicableStudy completedNCT00836186
What this trial is testing

Cytokine Expression During Radiation for Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 82
Testing effectiveness (Phase 2)Study completedNCT05785442
What this trial is testing

Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia

Who this might be right for
Community-acquired PneumoniaHospital-acquired Pneumonia
Hellenic Institute for the Study of Sepsis 60
Not applicableUnknownNCT05257694
What this trial is testing

Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning

Who this might be right for
Hepatocellular CarcinomaContrast-enhanced UltrasoundPrognosis+2 more
Ping Liang 1
Testing effectiveness (Phase 2)Study completedNCT00577642
What this trial is testing

Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates

Who this might be right for
Multiple Myeloma
Massachusetts General Hospital 29
Not applicableStudy completedNCT02807129
What this trial is testing

Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer

Who this might be right for
Cancer
CHU de Reims 296
Not applicableStudy completedNCT01638572
What this trial is testing

Exploring the Possibility to Use Glycosyltransferase as a Prognosis Marker of Neuroblastoma

Who this might be right for
Neuroblastoma
National Taiwan University Hospital 90
Not applicableStudy completedNCT02028975
What this trial is testing

Search for Biological Markers of Orosensory Perception of Fatty Acids in Healthy Subjects and Possible Modifications in Patients With Type 2 Diabetes and in Obese Non-diabetic Patients.

Who this might be right for
Type 2 Diabetes or Obesity Without Diabetes
Centre Hospitalier Universitaire Dijon 81
Not applicableUnknownNCT02448056
What this trial is testing

MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma

Who this might be right for
Carcinoma, HepatocellularMarker, Biological
National Taiwan University Hospital 150
Not applicableUnknownNCT03469219
What this trial is testing

Serum Granulysin Level as a Marker to Detect the Severity of Psoriasis

Who this might be right for
Psoriasis Vulgaris
Assiut University 45
Not applicableActive Not RecruitingNCT04227665
What this trial is testing

Identifying Biological Markers for Altitude Exposure and Use of Recombinant Human Erythropoietin (rHuEPO)

Who this might be right for
Healthy
University of Copenhagen 40
Next Page